Reporter
-
January 17, 2019
Building a pancreas
Vanderbilt investigators are defining the genetic programs that control the development of pancreatic beta cells — studies that could inform new cellular or regenerative therapies for diabetes. -
January 17, 2019
Research explores link between stem cell transplant, diabetes
About a decade ago, at the beginning of his career in academic medicine, Brian Engelhardt, MD, MSCI, noticed that many of his patients receiving a stem cell transplant for their blood cancer ended up with diabetes. -
January 17, 2019
Study points to alternate therapy for rare form of diabetes
Vanderbilt University Medical Center researchers say an unexpected finding during the cellular analysis of human pancreatic tissue has revealed new information about a rare type of diabetes and underscores the importance of genetic testing for some individuals diagnosed with type 1 diabetes. -
January 14, 2019
Vanderbilt set new heart, overall transplant record in 2018
Vanderbilt University Medical Center set a new record for total transplants among its five organ specialties in 2018 with more than 500 transplants. -
January 10, 2019
Grant to help address complexity of cancer care
Jeremy Warner, MD, MS, associate professor of Medicine and Biomedical Informatics, has been awarded a $1 million grant from the National Cancer Institute to develop software that will help clinicians keep up with the increasing complexity of cancer care. -
January 10, 2019
Study identifies novel genetic factors for colorectal cancer risk
A large-scale study conducted among East Asians and led by Vanderbilt researchers has identified multiple, previously unknown genetic risk factors for colorectal cancer. -
January 10, 2019
Lindsley receives ASPET award honoring drug discovery research
Craig Lindsley, PhD, a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is being honored by the American Society for Pharmacology and Experimental Therapeutics (ASPET) for his transformative approaches to identifying potential new drugs.